DHC Q4 2022: net loss $0.27/sh, normalized FFO $0.03/sh, SHOP occupancy up 380bps

DIVERSIFIED HEALTHCARE TRUST

2022-FY EPS reported -$0.07 revenue$1,283,566,000

Net loss attributable to common shareholders of $65.3M ($0.27 per share); Normalized FFO of $0.03 per share.
SHOP segment occupancy improved 380 bps YoY to 76.3%; revenues up 14.2% YoY.
Same property SHOP Cash Basis NOI surged 404.7% YoY to $9.9M; office same property NOI declined 0.9%.
Credit facility amended: fixed charge coverage ratio covenant waived through Jan 2024; commitments reduced to $450M after $136.4M repayment.
Office portfolio occupancy fell to 84.7% from 91.3% a year ago; new leases signed at 8.9% higher rents.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

DIVERSIFIED HEALTHCARE TRUST reported the quarter ended December 31, 2022 results: net income Net loss attributable to common shareholders of $65.3 million, or $0.27 per share, EPS $0.27 per share.

Period: the quarter ended December 31, 2022
Net income: Net loss attributable to common shareholders of $65.3 million, or $0.27 per share
EPS: $0.27 per share
Result: reported results

Exact text from the filing

On March 1, 2023, Diversified Healthcare Trust, or the Company, issued a press release regarding the Company’s results of operations and financial condition for the quarter and year ended December 31, 2022, and also provided certain supplemental operating and financial data for the quarter and year ended December 31, 2022.

View on SEC.gov

13 earnings releases filed in the last 30 days. Browse all earnings releases →

DIVERSIFIED HEALTHCARE TRUST filing history →

Source: SEC EDGAR

accession 0001075415-23-000006

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.